BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 11308435)

  • 1. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
    Moher D; Schulz KF; Altman D;
    JAMA; 2001 Apr; 285(15):1987-91. PubMed ID: 11308435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials.
    Moher D; Schulz KF; Altman DG;
    BMC Med Res Methodol; 2001; 1():2. PubMed ID: 11336663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
    Moher D; Schulz KF; Altman DG;
    J Am Podiatr Med Assoc; 2001 Sep; 91(8):437-42. PubMed ID: 11574648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.
    Moher D; Schulz KF; Altman DG;
    Clin Oral Investig; 2003 Mar; 7(1):2-7. PubMed ID: 12673431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.
    Moher D; Schulz KF; Altman DG
    Lancet; 2001 Apr; 357(9263):1191-4. PubMed ID: 11323066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001.
    Moher D; Schulz KF; Altman D;
    Explore (NY); 2005 Jan; 1(1):40-5. PubMed ID: 16791967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
    Moher D; Schulz KF; Altman DG;
    Ann Intern Med; 2001 Apr; 134(8):657-62. PubMed ID: 11304106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The revised CONSORT statement for reporting randomized trials: explanation and elaboration.
    Altman DG; Schulz KF; Moher D; Egger M; Davidoff F; Elbourne D; Gøtzsche PC; Lang T;
    Ann Intern Med; 2001 Apr; 134(8):663-94. PubMed ID: 11304107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration].
    Hopewel S; Clarke M; Moher D; Wager E; Middleton P; Altman DG; Schulz KF; The CG
    Zhong Xi Yi Jie He Xue Bao; 2008 Mar; 6(3):221-32. PubMed ID: 18334138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
    Piaggio G; Elbourne DR; Altman DG; Pocock SJ; Evans SJ;
    JAMA; 2006 Mar; 295(10):1152-60. PubMed ID: 16522836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.
    Hopewell S; Clarke M; Moher D; Wager E; Middleton P; Altman DG; Schulz KF;
    PLoS Med; 2008 Jan; 5(1):e20. PubMed ID: 18215107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better reporting of harms in randomized trials: an extension of the CONSORT statement.
    Ioannidis JP; Evans SJ; Gøtzsche PC; O'Neill RT; Altman DG; Schulz K; Moher D;
    Ann Intern Med; 2004 Nov; 141(10):781-8. PubMed ID: 15545678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Randomized clinical trials (CONSORT)].
    Cobos-Carbó A;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():21-7. PubMed ID: 16464423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement.
    Juszczak E; Altman DG; Hopewell S; Schulz K
    JAMA; 2019 Apr; 321(16):1610-1620. PubMed ID: 31012939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.
    Piaggio G; Elbourne DR; Pocock SJ; Evans SJ; Altman DG;
    JAMA; 2012 Dec; 308(24):2594-604. PubMed ID: 23268518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation.
    Moher D; Jones A; Lepage L;
    JAMA; 2001 Apr; 285(15):1992-5. PubMed ID: 11308436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.
    Boutron I; Altman DG; Moher D; Schulz KF; Ravaud P;
    Ann Intern Med; 2017 Jul; 167(1):40-47. PubMed ID: 28630973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.